ETON
NASDAQEton Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
Price History
Learn Why It Moved
Educational concepts related to this stock
Biotech Catalyst
Biotech stocks are often driven by FDA approvals, trial results, and regulatory news. Learn how binary catalysts work.
Insider Activity
Check if insiders have been buying or selling. Insider buying is one of the strongest signals in small cap trading.
Dilution Risk
Check SEC filings for active shelf registrations. Dilution is the #1 risk in small cap trading.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.